江中药业 (600750)

Jiangzhong Pharmaceutical Co., Ltd.

ASH

Tags

SSE 380 IndexSSE Corporate Governance IndexSpecial Purpose LoansTraditional Chinese MedicineCSI Central State-Owned Enterprises IndexInsurance Heavy PositionsPension FundsBroker Heavy PositionsPharmaceutical ManufacturingPharmaceuticals and HealthcareInvestments in Financial InstitutionsGuoxin Value IndexBaijiu (Chinese Liquor) ConceptHigh-Performing StocksMargin Trading and Securities LendingChina Securities Finance and Central Huijin HoldingsHigh-Dividend StocksHigh-Dividend Yield Stocks医药生物中药Ⅱ

K-Line Chart

No K-line data available

Company NameChina Resources Jiangzhong Pharmaceutical Co., Ltd.
Listing Date1996-09-23
Issue Price6.8RMB
Registered Capital63495.328910k RMB
Legal RepresentativeLiu Weiquan
Registered AddressNo. 788 Huoju Avenue, High-tech Zone, Nanchang City, Jiangxi Province
IndustryTraditional Chinese Medicine II
Main BusinessProduction, research and development, and sales of pharmaceuticals and health products (including functional foods, the same below).
Company ProfileChina Resources Jiangzhong Pharmaceutical Group Co., Ltd. (referred to as China Resources Jiangzhong) originated from Jiangzhong Pharmaceutical Factory, a university-run enterprise of Jiangxi College of Traditional Chinese Medicine, established in October 1969. In 1998, it restructured Dongfeng Pharmaceutical and formed the Jiangzhong Group. In 2004, it was listed as a key state-owned enterprise under the jurisdiction of Jiangxi Province. In February 2019, China Resources Pharmaceutical strategically restructured the Jiangzhong Group, officially renamed it China Resources Jiangzhong, making it a primary profit center of China Resources Group. The company has one A-share listed company (Jiangzhong Pharmaceutical, stock code: 600750), mainly engaged in the research and development, production, and sales of Chinese patent medicines and health foods. It owns two well-known Chinese trademarks, "Jiangzhong" and "Chuyuan," and two famous Jiangxi Province trademarks, "Yang Jisheng" and "Sanghai." Among them, the "Jiangzhong" brand has been listed on the World Brand Lab's "China's 500 Most Valuable Brands" for 16 consecutive years, with a brand value of 23.736 billion yuan. Main products include Jiangzhong brand Jianwei Xiaoshi Tablets, Jiangzhong brand Compound Caoshanhu Throat Tablets, Jiangzhong Lihuo Lactobacillus Tablets, Chuyuan brand Compound Amino Acid Oral Solution, Shenlingcao Oral Solution, Boluoke, Compound Fresh Bamboo Sap Oral Liquid, Paishi Granules, Sanghai Jinwei, Bazhen Yimu Capsules, etc. As of the end of 2018, the company's total assets were 9.684 billion yuan, net assets were 3.199 billion yuan, operating revenue was 9.405 billion yuan, and annual profit and tax created were 887 million yuan.

Stock Details

1. Key Indicators

  • Total Shares(W): 63499.60
  • Circulating A-Shares(W): 62729.24
  • Earnings Per Share(RMB): 1.08
  • Net Assets Per Share(RMB): 5.98
  • Operating Revenue(W RMB): 293317.22
  • Total Profit(W RMB): 92369.51
  • **Net Profit Attributable to Parent(W RMB) **: 68345.00
  • Net Profit Growth Rate(%): 7.74
  • Weighted Return on Equity(%): 17.03
  • Operating Cash Flow Per Share(RMB): 1.53
  • Undistributed Profit Per Share(RMB): 3.80
  • Capital Reserve Per Share(RMB): 0.74

2. Main Business

The main business covers:

  • Production, R&D and sales of over-the-counter drugs and health products (including functional foods)

3. Company Basic Information

  • Company Name: Jiangzhong Pharmaceutical Co., Ltd.
  • Listing Date: 1996-09-23
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 788 Huoju Avenue, High-tech Zone, Nanchang City, Jiangxi Province
  • Website: https://www.jzjt.com/
  • Company Profile: The company was exclusively established by Jiangxi Dongfeng Pharmaceutical Co., Ltd. in April 1996, initially converting part of its net assets into 38.4 million state shares. After the initial online pricing issuance on August 29, 1996, the total number of shares at the time of listing was 62.4 million shares; 2.4 million internal employee shares will be traded on the market after the public shares have been listed and circulated for half a year.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Resources Jiangzhong Pharmaceutical Group Co., Ltd. General Legal Person 27385.58 43.66
2 Orient Securities Company Limited Securities Company 1828.72 2.92
3 Central Huijin Asset Management Ltd. Special Legal Person 1555.11 2.48
4 National Social Security Fund 115 Combination Social Security Fund 1550.00 2.47
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1171.23 1.87
6 Sunshine Life Insurance Co., Ltd. - Traditional Insurance Products Insurance 1162.45 1.85
7 GF Stable Growth Open-end Securities Investment Fund Class A Fund 1091.07 1.74
8 Guolian Minsheng Securities Co., Ltd. Securities Company 350.50 0.56
9 Invesco Great Wall CSI Dividend Low Volatility 100 ETF Fund 296.67 0.47
10 Qianhai Kaiyuan Chinese Medicine Research Selected Stock Initiating Fund Class A Fund 264.67 0.42

5. Concept Sectors

  • Baijiu Concept
  • Margin Trading & Securities Lending
  • Insurance Heavy Holdings
  • Financial Participation
  • High-Performance Stocks
  • Securities Company Heavy Holdings
  • Social Security Fund Heavy Holdings
  • High Dividend Stocks
  • China Securities Finance & Central Huijin
  • Pension Fund
  • High Dividend Payout Stocks
  • Special Loans
  • SSE Corporate Governance Index
  • SSE 380 Index
  • CSI Central Enterprises Index
  • Guoxin Value Index

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information